During the past decade, General Hospital Murska Sobota conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital Murska Sobota" #1 sponsor was "Abivax S.A." with 2 trials, followed by "Associazione Qol-one" with 1 trials sponsored, "General Hospital Murska Sobota" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Inventiva Pharma" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Murska Sobota" #1 collaborator was "Community Health Center Murska Sobota" with 1 trials as a collaborator, "Murska Sobota Municipiality" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator, "Slovenian Research Agency" with 1 trials as a collaborator and "University of Ljubljana" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital Murska Sobota" are "Ulcerative Colitis" (2 trials), "Angina Pectoris" (1 trials), "Coronary Artery Disease" (1 trials), "Diabetic Foot Ulcer" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "General Hospital Murska Sobota" in a lesser frequency.

Most popular intervention types in "General Hospital Murska Sobota" are "Drug" (5 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ABX464" (1 trials), "ABX464 100mg" (1 trials), "ABX464 25mg" (1 trials) and "ABX464 50mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Murska Sobota" are 7 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital Murska Sobota". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in General Hospital Murska Sobota, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Murska Sobota, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".